Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-cyclopropyl-7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride
2. Bay Y 3118
3. Bay Y3118
4. Bay-y3118
1. 144194-96-7
2. Bay Y3118
3. Bay-y3118
4. Bay-y-3118
5. Bayy3118
6. Ms2o1a809w
7. Bay-y 3118
8. 7-[(4as,7as)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic Acid;hydrochloride
9. Bay Y 3118
10. 8-chloro-1-cyclopropyl-6-fluoro-7-((4as,7as)-hexahydro-1h-pyrrolo[3,4-b]pyridin-6(2h)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
11. Unii-ms2o1a809w
12. Ccris 8689
13. Schembl1857905
14. Bayy-3118
15. Bay Y-3118
16. 1-cyclopropyl-7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride
17. 3-quinolinecarboxylic Acid, 8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-7-(octahydro-6h-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, Monohydrochloride, (4as-cis)-
18. Q27284209
19. 3-quinolinecarboxylic Acid, 8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4as,7as)-octahydro-6h-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, Hydrochloride (1:1)
| Molecular Weight | 442.3 g/mol |
|---|---|
| Molecular Formula | C20H22Cl2FN3O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 441.1022251 g/mol |
| Monoisotopic Mass | 441.1022251 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 715 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Bay Y3118 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bay Y3118, including repackagers and relabelers. The FDA regulates Bay Y3118 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bay Y3118 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bay Y3118 supplier is an individual or a company that provides Bay Y3118 active pharmaceutical ingredient (API) or Bay Y3118 finished formulations upon request. The Bay Y3118 suppliers may include Bay Y3118 API manufacturers, exporters, distributors and traders.
click here to find a list of Bay Y3118 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bay Y3118 DMF (Drug Master File) is a document detailing the whole manufacturing process of Bay Y3118 active pharmaceutical ingredient (API) in detail. Different forms of Bay Y3118 DMFs exist exist since differing nations have different regulations, such as Bay Y3118 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bay Y3118 DMF submitted to regulatory agencies in the US is known as a USDMF. Bay Y3118 USDMF includes data on Bay Y3118's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bay Y3118 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bay Y3118 suppliers with USDMF on PharmaCompass.
Bay Y3118 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bay Y3118 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bay Y3118 GMP manufacturer or Bay Y3118 GMP API supplier for your needs.
A Bay Y3118 CoA (Certificate of Analysis) is a formal document that attests to Bay Y3118's compliance with Bay Y3118 specifications and serves as a tool for batch-level quality control.
Bay Y3118 CoA mostly includes findings from lab analyses of a specific batch. For each Bay Y3118 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bay Y3118 may be tested according to a variety of international standards, such as European Pharmacopoeia (Bay Y3118 EP), Bay Y3118 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bay Y3118 USP).
LOOKING FOR A SUPPLIER?
